Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A21839 | 25009583 | Exp Ther Med | Evaluation of fatty liver fibrosis in rabbits using real-time shear wave elastography. | 2014 | Details |
| A21840 | 25009406 | World J Gastroenterol | Hemorrhagic ascites from spontaneous ectopic mesenteric varices rupture in NASH induced cirrhosis and successful outcome: a case report. | 2014 | Details |
| A21841 | 25009382 | World J Gastroenterol | Non-alcoholic fatty liver disease and thyroid dysfunction: a systematic review. | 2014 | Details |
| A21842 | 25008241 | Mol Cell Endocrinol | Role of aquaglyceroporins and caveolins in energy and metabolic homeostasis. | 2014 | Details |
| A21844 | 25004910 | Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub | The prevalence of nonalcoholic liver steatosis in patients with type 2 diabetes mellitus in the Czech Republic. | 2014 | Details |
| A21845 | 25004459 | Clin Gastroenterol Hepatol | Validation of noninvasive methods for detecting hepatic steatosis in patients with human immunodeficiency virus infection. | 2014 | Details |
| A21846 | 25003952 | J Hepatol | Thioredoxin-interacting protein mediates hepatic lipogenesis and inflammation via PRMT1 and PGC-1α regulation in vitro and in vivo. | 2014 | Details |
| A21847 | 25003671 | Turk J Gastroenterol | Role of gut microbiota: obesity and NAFLD. | 2014 | Details |
| A21848 | 25003670 | Turk J Gastroenterol | Nonalcoholic fatty liver disease: diagnosis, pathogenesis, and management. | 2014 | Details |
| A21849 | 25003263 | Arq Gastroenterol | Grading scale of visceral adipose tissue thickness and their relation to the nonalcoholic fatty liver disease. | 2015 | Details |
| A21850 | 25003023 | FEBS Open Bio | Senescence marker protein-30/superoxide dismutase 1 double knockout mice exhibit increased oxidative stress and hepatic steatosis. | 2014 | Details |
| A21851 | 25002154 | Gastroenterol Rep (Oxf) | Simple non-invasive biomarkers of advanced fibrosis in the evaluation of non-alcoholic fatty liver disease. | 2014 | Details |
| A21852 | 25000850 | Clin Nutr | Novel pathway for iron deficiency in pediatric non-alcoholic steatohepatitis. | 2014 | Details |
| A21853 | 24998970 | Toxicol Appl Pharmacol | Evaluation of Aroclor 1260 exposure in a mouse model of diet-induced obesity and non-alcoholic fatty liver disease. | 2014 | Details |
| A21854 | 24998389 | Sci Rep | Lycium barbarum polysaccharides therapeutically improve hepatic functions in non-alcoholic steatohepatitis rats and cellular steatosis model. | 2014 | Details |
| A21855 | 24997826 | Zhongguo Yi Xue Ke Xue Yuan Xue Bao | Effect of piglitazone and metformin on retinol-binding protein-4 and adiponectin in patients with type 2 diabetes mellitus complicated with non-alcohol fatty acid liver diseases. | 2014 | Details |
| A21856 | 24997224 | Exp Mol Pathol | TLR3/4 signaling is mediated via the NFκB-CXCR4/7 pathway in human alcoholic hepatitis and non-alcoholic steatohepatitis which formed Mallory-Denk bodies. | 2014 | Details |
| A21857 | 24995693 | Hepatology | The transrepressive activity of peroxisome proliferator-activated receptor alpha is necessary and sufficient to prevent liver fibrosis in mice. | 2014 | Details |
| A21858 | 24994581 | Panminerva Med | Serum adipokine levels in overweight patients and their relationship with non-alcoholic fatty liver disease. | 2014 | Details |
| A21859 | 24993831 | J Biol Chem | Hepatic differentiated embryo-chondrocyte-expressed gene 1 (Dec1) inhibits sterol regulatory element-binding protein-1c (Srebp-1c) expression and alleviates fatty liver phenotype. | 2014 | Details |
| A21860 | 24993341 | Int Immunopharmacol | Involvement of hepatic peroxisome proliferator-activated receptor α/γ in the therapeutic effect of osthole on high-fat and high-sucrose-induced steatohepatitis in rats. | 2014 | Details |
| A21861 | 24993337 | Int J Mol Med | Exendin‑4, a glucagon‑like peptide‑1 receptor agonist, modulates hepatic fatty acid composition and Δ‑5‑desaturase index in a murine model of non‑alcoholic steatohepatitis. | 2014 | Details |
| A21862 | 24993140 | Blood Purif | Non-alcoholic fatty liver disease proven by transient elastography in hemodialysis patients: is it a new risk factor for adverse cardiovascular events? | 2014 | Details |
| A21863 | 24992162 | Genet Test Mol Biomarkers | Relationship of SREBP-2 rs2228314 G>C polymorphism with nonalcoholic fatty liver disease in a Han Chinese population. | 2014 | Details |
| A21864 | 24990583 | Scand J Gastroenterol | Increased risk of cirrhosis and hepatocellular cancer during long-term follow-up of patients with biopsy-proven NAFLD. | 2014 | Details |
| A21865 | 24990331 | Intern Med | Prognostic factors for regression from impaired glucose tolerance to normal glucose regulation in Japanese patients with nonalcoholic fatty liver disease. | 2014 | Details |
| A21867 | 24990270 | BMC Gastroenterol | Characterization and prognosis of patients with hepatocellular carcinoma (HCC) in the non-cirrhotic liver. | 2014 | Details |
| A21868 | 24989624 | Expert Opin Drug Metab Toxicol | Drug disposition alterations in liver disease: extrahepatic effects in cholestasis and nonalcoholic steatohepatitis. | 2014 | Details |
| A21869 | 24989169 | Scand J Gastroenterol | Moderate to severe, but not mild, nonalcoholic fatty liver disease associated with increased risk of gallstone disease. | 2014 | Details |
| A21870 | 24989077 | J Gastroenterol Hepatol | Childhood adiposity trajectories and risk of nonalcoholic fatty liver disease in adolescents. | 2015 | Details |
| A21871 | 24988316 | PLoS One | Non-invasive separation of alcoholic and non-alcoholic liver disease with predictive modeling. | 2014 | Details |
| A21874 | 24987758 | J Magn Reson Imaging | Spatial distribution of MRI-Determined hepatic proton density fat fraction in adults with nonalcoholic fatty liver disease. | 2014 | Details |
| A21875 | 24987492 | Oxid Med Cell Longev | Serum oxidative stress markers and lipidomic profile to detect NASH patients responsive to an antioxidant treatment: a pilot study. | 2014 | Details |
| A21876 | 24986741 | J Transl Med | Progression of diet induced nonalcoholic steatohepatitis is accompanied by increased expression of Kruppel-like-factor 10 in mice. | 2014 | Details |
| A21877 | 24985011 | Nutrition | Resveratrol attenuates hepatic steatosis in high-fat fed mice by decreasing lipogenesis and inflammation. | 2013 | Details |
| A21878 | 24984998 | Nutrition | Effects of a novel therapeutic diet on liver enzymes and coagulating factors in patients with non-alcoholic fatty liver disease: A parallel randomized trial. | 2013 | Details |
| A21879 | 24983359 | PLoS One | L-carnitine prevents progression of non-alcoholic steatohepatitis in a mouse model with upregulation of mitochondrial pathway. | 2014 | Details |
| A21880 | 24983336 | Med Sci Sports Exerc | Treating NAFLD in OLETF rats with vigorous-intensity interval exercise training. | 2015 | Details |
| A21882 | 24978903 | Nat Commun | TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease. | 2014 | Details |
| A21884 | 24978432 | Cancers (Basel) | Fibrogenesis and Carcinogenesis in Nonalcoholic Steatohepatitis (NASH): Involvement of Matrix Metalloproteinases (MMPs) and Tissue Inhibitors of Metalloproteinase (TIMPs). | 2014 | Details |
| A21885 | 24977111 | Curr Hepatol Rep | Hepatic steatosis and steatohepatitis: Are they really two distinct entities? | 2014 | Details |
| A21886 | 24976805 | Gastroenterol Hepatol (N Y) | Controversies in the Diagnosis and Management of NAFLD and NASH. | 2014 | Details |
| A21887 | 24976715 | World J Gastroenterol | Role of endoscopy in the bariatric surgery of patients. | 2014 | Details |
| A21888 | 24976709 | World J Gastroenterol | Nonalcoholic fatty liver disease: updates in noninvasive diagnosis and correlation with cardiovascular disease. | 2014 | Details |
| A21889 | 24976563 | Hepatol Res | Influence of lifestyle-related diseases and age on the development and progression of non-alcoholic fatty liver disease. | 2014 | Details |
| A21890 | 24976430 | Nutrition | Effect of vitamin E supplementation on aminotransferase levels in patients with NAFLD, NASH, and CHC: results from a meta-analysis. | 2014 | Details |
| A21891 | 24976401 | Biochem Biophys Res Commun | NHE1 deficiency in liver: implications for non-alcoholic fatty liver disease. | 2014 | Details |
| A21892 | 24976364 | Hepatol Res | Eicosapentaenoic acid/arachidonic acid ratio as a possible link between non-alcoholic fatty liver disease and cardiovascular disease. | 2014 | Details |
| A21893 | 24976277 | Saudi J Gastroenterol | Does vitamin E improve the outcomes of pediatric nonalcoholic fatty liver disease? A systematic review and meta-analysis. | 2015 | Details |
| A21895 | 24975463 | Diabet Med | Serum fetuin-A concentration predicts glycaemic outcomes in people with prediabetes: a prospective study from eastern India. | 2014 | Details |
| A21896 | 24975216 | J Nutr Sci Vitaminol (Tokyo) | Retinol status and expression of retinol-related proteins in methionine-choline deficient rats. | 2014 | Details |
| A21897 | 24975050 | Basic Clin Pharmacol Toxicol | Effects of antihypertensive and triglyceride-lowering agents on hepatic copper concentrations in rats with fatty liver disease. | 2014 | Details |
| A21898 | 24974878 | Ann Gastroenterol | Insulin resistance in euglycemic cirrhosis. | 2014 | Details |
| A21899 | 24974489 | J Assoc Physicians India | Hepatocyte growth factor, adiponectin and hepatic histopathology in non-alcoholic steatohepatitis. | 2013 | Details |
| A21900 | 30310479 | Eur Cardiol | The Role of Non-alcoholic Fatty Liver Disease in Cardiovascular Disease. | 2014 | Details |
| A21901 | 29699348 | Euroasian J Hepatogastroenterol | Serum Resistin Level and Its Receptor Gene Expression in Liver Biopsy as Predictors for the Severity of Nonalcoholic Fatty Liver Disease. | 2014 | Details |
| A21902 | 24973357 | J Endocrinol | 20 years of leptin: leptin in common obesity and associated disorders of metabolism. | 2014 | Details |
| A21903 | 24973316 | Gut | Circulating microRNA signature in non-alcoholic fatty liver disease: from serum non-coding RNAs to liver histology and disease pathogenesis. | 2014 | Details |
| A21904 | 24971392 | ScientificWorldJournal | Methotrexate-associated nonalcoholic fatty liver disease with transaminitis in rheumatoid arthritis. | 2014 | Details |
| A21905 | 24969468 | Anal Bioanal Chem | In vitro/in vivo screening of oxidative homeostasis and damage to DNA, protein, and lipids using UPLC/MS-MS. | 2014 | Details |
| A21906 | 24968846 | Nan Fang Yi Ke Da Xue Xue Bao | [Therapeutic effect of saxagliptin in rat models of nonalcoholic fatty liver and type 2 diabetes]. | 2014 | Details |
| A21907 | 24968841 | Nan Fang Yi Ke Da Xue Xue Bao | [Establishment of a L-02 cell model of hepatic steatosis]. | 2014 | Details |
| A21908 | 24968737 | Endocrine | Does vitamin D improve liver enzymes, oxidative stress, and inflammatory biomarkers in adults with non-alcoholic fatty liver disease? A randomized clinical trial. | 2014 | Details |
| A21909 | 24968200 | Br J Nutr | Beneficial effects of soluble dietary Jerusalem artichoke (Helianthus tuberosus) in the prevention of the onset of type 2 diabetes and non-alcoholic fatty liver disease in high-fructose diet-fed rats. | 2014 | Details |
| A21910 | 24967351 | Biomed Res Int | Enhanced amelioration of high-fat diet-induced fatty liver by docosahexaenoic acid and lysine supplementations. | 2014 | Details |
| A21911 | 24966609 | World J Gastroenterol | Radiologic evaluation of nonalcoholic fatty liver disease. | 2014 | Details |
| A21912 | 24966608 | World J Gastroenterol | Role of gut microbiota and Toll-like receptors in nonalcoholic fatty liver disease. | 2014 | Details |
| A21913 | 24966607 | World J Gastroenterol | Effects of resveratrol and other polyphenols in hepatic steatosis. | 2014 | Details |
| A21914 | 24966606 | World J Gastroenterol | Incretin based therapies: a novel treatment approach for non-alcoholic fatty liver disease. | 2014 | Details |
| A21915 | 24966605 | World J Gastroenterol | Pediatric fatty liver disease: role of ethnicity and genetics. | 2014 | Details |
| A21916 | 24966604 | World J Gastroenterol | Mediterranean diet and non-alcoholic fatty liver disease: new therapeutic option around the corner? | 2014 | Details |
| A21917 | 24966603 | World J Gastroenterol | Role of autophagy in the pathophysiology of nonalcoholic fatty liver disease: a controversial issue. | 2014 | Details |
| A21918 | 24966598 | World J Gastroenterol | Gallstones in patients with liver cirrhosis: incidence, etiology, clinical and therapeutical aspects. | 2014 | Details |
| A21919 | 24966597 | World J Gastroenterol | Cellular and molecular mechanisms in the pathogenesis of liver fibrosis: An update. | 2014 | Details |
| A21920 | 24966582 | World J Gastroenterol | Pathogenesis and significance of hepatitis C virus steatosis: an update on survival strategy of a successful pathogen. | 2014 | Details |
| A21921 | 24965391 | J BUON | Chemotherapy-associated hepatotoxicity in colorectal cancer. | 2014 | Details |
| A21922 | 24965234 | J Surg Oncol | Nonalcoholic fatty liver disease after pancreatoduodenectomy is closely associated with postoperative pancreatic exocrine insufficiency. | 2014 | Details |
| A21923 | 24963148 | EMBO Mol Med | A positive feedback loop between RIP3 and JNK controls non-alcoholic steatohepatitis. | 2014 | Details |
| A21924 | 24962805 | Diabetes Obes Metab | Abdominal subcutaneous adipose tissue insulin resistance and lipolysis in patients with non-alcoholic steatohepatitis. | 2014 | Details |
| A21926 | 24961681 | Pediatr Obes | Oral fructose absorption in obese children with non-alcoholic fatty liver disease. | 2014 | Details |
| A21927 | 24961607 | Liver Transpl | Recurrent or de novo nonalcoholic fatty liver disease after liver transplantation: natural history based on liver biopsy analysis. | 2014 | Details |
| A21928 | 24961024 | J Egypt Soc Parasitol | Assessment of the co-incidence between non alcoholic fatty liver disease and carotid atherosclerosis. | 2014 | Details |
| A21930 | 24958099 | Mol Cell Biol | Susceptibility of Nrf2-null mice to steatohepatitis and cirrhosis upon consumption of a high-fat diet is associated with oxidative stress, perturbation of the unfolded protein response, and disturbance in the expression of metabolic enzymes but not with insulin resistance. | 2014 | Details |
| A21931 | 24957697 | Scand J Gastroenterol | Serum AFBP levels are elevated in patients with nonalcoholic fatty liver disease. | 2014 | Details |
| A21932 | 24956534 | Atherosclerosis | Associations between nonalcoholic fatty liver disease and subclinical atherosclerosis in middle-aged adults: the Coronary Artery Risk Development in Young Adults Study. | 2014 | Details |
| A21933 | 24955981 | Biochem Pharmacol | LXR-α antagonist meso-dihydroguaiaretic acid attenuates high-fat diet-induced nonalcoholic fatty liver. | 2014 | Details |
| A21934 | 24955455 | J Gastroenterol Hepatol | Associations between intakes of individual nutrients or whole food groups and non-alcoholic fatty liver disease among Korean adults. | 2014 | Details |
| A21935 | 24953607 | Life Sci | Testosterone suppresses the expression of regulatory enzymes of fatty acid synthesis and protects against hepatic steatosis in cholesterol-fed androgen deficient mice. | 2014 | Details |
| A21936 | 24953204 | Dig Liver Dis | Determinants of alanine aminotransferase levels in a large population from Southern Italy: relationship between alanine aminotransferase and age. | 2014 | Details |
| A21937 | 24952996 | Neurogastroenterol Motil | Damage to enteric neurons occurs in mice that develop fatty liver disease but not diabetes in response to a high-fat diet. | 2014 | Details |
| A21938 | 24952382 | Lipids Health Dis | Nonalcoholic steatohepatitis is associated with an atherogenic lipoprotein subfraction profile. | 2014 | Details |
| A21939 | 24951302 | Gastroenterol Hepatol | [Liver diseases in the elderly]. | 2014 | Details |
| A21940 | 24950438 | Molecules | Sulfur amino acids in diet-induced fatty liver: a new perspective based on recent findings. | 2014 | Details |
| A21941 | 24950230 | PLoS One | β-Adrenergic agonist and antagonist regulation of autophagy in HepG2 cells, primary mouse hepatocytes, and mouse liver. | 2014 | Details |
| A21942 | 24949725 | Am J Med Sci | Oxidative balance in lymphocytes from patients with nonalcoholic steatohepatitis. | 2014 | Details |
| A21944 | 24947770 | Eur J Intern Med | Non-alcoholic fatty liver disease, metabolic syndrome and patatin-like phospholipase domain-containing protein3 gene variants. | 2014 | Details |
| A21945 | 24947350 | Diabetes | SIRT1 mediates the effect of GLP-1 receptor agonist exenatide on ameliorating hepatic steatosis. | 2014 | Details |
| A21946 | 24946282 | J Hepatol | A common polymorphism in the NCAN gene is associated with hepatocellular carcinoma in alcoholic liver disease. | 2014 | Details |
| A21947 | 24946279 | J Hepatol | ASMase regulates autophagy and lysosomal membrane permeabilization and its inhibition prevents early stage non-alcoholic steatohepatitis. | 2014 | Details |
| A21948 | 24944898 | Mol Metab | Osteopontin: A novel regulator at the cross roads of inflammation, obesity and diabetes. | 2014 | Details |